Assistant director of drug development at Sarah Cannon Research Institute. I focus on phase 1 trials for patients with GI malignancies
Denver, CO
Joined July 2010
- Tweets125
- Following424
- Followers261
- Likes1.1K
Jason Timothy Henry retweeted
Its here!
@US_FDA guidance on Conducting Clinical Trials With Decentralized Elements is out!
Protocols should specify whether
- Telehealth visits is appropriate
- Local health care providers can conduct study visits
fda.gov/regulatory-informati…
Jason Timothy Henry retweeted
🤩🤩A splendid new beginning at the rend of a 40-Year Quest: The 1st KRASG12D Inhibitor in #PDAC
@CD_AACR
doi.org/10.1158/2159-8290.CD…
doi.org/10.1158/2159-8290.CD…
👏 Super impressive effects of MRTX113 in immunocompetent mice - IO combo for durable responses in men?
@myESMO @OncoAlert
Interesting paper. Ongoing work refining biomarkers of CPI response in mss GI cancers
thelancet.com/journals/lanon…
Jason Timothy Henry retweeted
My father Darrell- Athlete, inventor, farmer, coach, NDSU fan...Inspired generations of ND athletes… Taught me to believe that “everything is possible!” The golf course he designed in Westhope and the pitching machine he made from scratch circa 1962! – at Marina del Rey, CA
Jason Timothy Henry retweeted
🔥Detection of FGFR2 fusions is challenging❗️
doi.org/10.1038/s41416-022-0…
✅🔥🎯in #Cholangiocarcinoma #PancreaticCancer...
👇we provide detailed analysis on genomic architecture of FGFR2 fusions & implication for molecular testing
👉know your NGS Panel
@myESMO @enscca @OncoAlert
Jason Timothy Henry retweeted
MYTH: We don't have a solution to nuclear's "waste problem"
REALITY: Nuclear waste isn't a problem. In fact, it’s the best solution we have to meeting our energy needs while protecting the natural environment!
Here's what you need to know:
Jason Timothy Henry retweeted
It would be hard to overstate how exciting these early results are in late-line MSS CRC patients without liver involvement. From non existent ORR in nearly all IO only trials, to 42% in those without liver involvement.
I highly look forward to future results and confirmation!
Jason Timothy Henry retweeted
Super cool first-in-human if PC14586, TP53 activator in cancers with Y220C mutation presented by @cathy_ileana_md @MDAndersonNews. RR 32% for biologically active doses. For me I have a winner of the phase I session at #ASCO22 #DruggingDifficultTargets
Impressive and very encouraging!
Outstanding new science at #ESMO21
💥CLD 18.2 CAR-T cells effective in GI cancers 💥
ORR 61% in 3L+ #gastriccancer
#ESMO21 @myESMO @OncoAlert
Jason Timothy Henry retweeted
When I think of Gabe, I feel compelled to run. So I’ll do just that today in honor of 2 years since her passing 💙 She said, “It’s okay to struggle. It’s not okay to give up.” Thinking of Justin & all of you who have been changed by her powerful legacy. We love you, Gabe!
Jason Timothy Henry retweeted
I’m honored to receive a @ConquerCancerFd #ASCO21 Young Investigator Award to study the association between #discrimination, trust, and pain outcomes after mastectomy among Black women w/ breast cancer #bcsm #HealthEquity #HealthDisparities
Pleased to share our article on #KRAS G12C #CRC characterizing this newly targetable population with suggestions for future therapeutic partners! Thanks to @Benjohnson1112 & @skopetz for everything along the way. @MDAndersonNews @ASCO_pubs @DavidHongMD
ascopubs.org/doi/abs/10.1200…
Jason Timothy Henry retweeted
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper | Nature Reviews Clinical Oncology. Notes the opportunities and gaps in knowledge. @VanMorrisMD and Arvind Dasari @MDAndersonNews nature.com/articles/s41571-0…
Jason Timothy Henry retweeted
Saw a lady who had a 3 cm lung tumor in March and her surgery was postponed due to an embargo on 'elective surgeries'. She came yesterday with a malignant pleural effusion. This is something we as oncologists long feared. Cancer care is not 'elective' @StephenVLiu @AMansfieldMD
Agree with all, also happy to answer questions!
This Post is from an account that no longer exists. Learn more
Jason Timothy Henry retweeted
Wow, doubling of PFS with pembro over chemo/biologic in patients w/ untreated MMRd/MSI-H metastatic #colorectalcancer, and 1/3 of the grade 3-5 AEs! Await OS data from KEYNOTE-177 but the PFS data is compelling #ASCO20 @ASCO @RueschCenter @OncoAlert
meetinglibrary.asco.org/reco…
Jason Timothy Henry retweeted
BEACON results for #CRCsm now available after #ESMO2019 presentation with @NEJM coordinated publication. Congratulations to my coauthors, Array team, and with appreciation for the patients willingness to participate. @pfizer @MDAndersonNews
As an oncologist and a gopher fan this hits close to home. @caseyob14 you are an inspiration! You do have the whole world behind you, and you are an important voice for those who are currently dealing with this horrible disease. @Coach_Fleck You found your team MVP this year!
"You have the whole world behind you."
Listen to the role @GopherFootball alum @EricDecker87 had on Casey O'Brien's battle with cancer.
Seemingly small gestures can lead to such amazing things.